SCHEMBL4637778

SCHEMBL4637778

CCOC(=O)c1nnn(Cc2cc(Cl)cc(Cl)c2)c1-c1ccncc1

nearest known ligand 0.68

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 8/20 0.68
CASP1 P29466 1/20 0.46
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
CA4 P22748 1/20 0.45
CA9 Q16790 1/20 0.45
KCNMA1 Q12791 1/20 0.43
GCGR P47871 1/20 0.42
KMT2A Q03164 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
POLB P06746 1/20 0.41
CDC7 O00311 1/20 0.41
DBF4 Q9UBU7 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4639420 0.84 CYP19A1 (0.60) CYP19A1KMT2ASMN1; SMN2POLB
SCHEMBL4639451 0.84 CYP19A1 (0.48) CYP19A1SMN1; SMN2POLBCYP2C9
SCHEMBL25333493 0.81 CYP19A1 (0.56) CYP19A1KMT2ASMN1; SMN2L3MBTL1
SCHEMBL4638606 0.81 CYP19A1 (0.56) CYP19A1KMT2ASMN1; SMN2L3MBTL1
SCHEMBL4638522 0.81 CYP19A1 (0.44) CYP19A1SMN1; SMN2POLBCYP1A2CYP2C9
SCHEMBL4637938 0.80 CYP19A1 (0.55) CYP19A1KMT2ASMN1; SMN2L3MBTL1
SCHEMBL22816295 0.77 CYP19A1 (0.77) CYP19A1CA1CA2CA4CA9
SCHEMBL4637971 0.77 CYP19A1 (0.50) CYP19A1SMN1; SMN2CYP1A2
SCHEMBL22815805 0.76 CYP19A1 (0.74) CYP19A1CA1CA2CA4CA9
SCHEMBL4637752 0.74 CYP19A1 (0.74) CYP19A1KMT2ASMN1; SMN2POLBCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1501808-B1 TACHYKININ RECEPTOR ANTAGONISTS LILLY CO ELI (US) 2008-07-02 EP disclosed
EP-1501809-B1 TRIAZOLE DERIVATIVES AS TACHYKININ RECEPTOR ANTAGONISTS LILLY CO ELI (US) 2008-01-16 EP disclosed